Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal vs IV Ketorolac for Pediatric Migraine
NCT02358681Phase 3Completed
- Sponsor
- Columbia University
- Start
- Jun 2015
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ketorolac in migraine, sponsored by Columbia University. Started Jun 2015; status: completed.
02
Drugs
ketorolac
03
Conditions
migraine
Beyond the preview
Go deeper on NCT02358681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02358681.